Table 2.
Most frequently reported adverse events
| Once weekly |
Once every 2 weeks |
|||||
|---|---|---|---|---|---|---|
| Placebo | 5 mg | 10 mg | 20 mg | 10 mg | 20 mg | |
| n | 49* | 50* | 49* | 50* | 50* | 49* |
| Nausea | 3 (6) | 11 (22) | 12 (24) | 26 (52) | 16 (32) | 20 (10) |
| Diarrhea | 4 (8) | 4 (8) | 5 (10) | 5 (10) | 8 (16) | 9 (18) |
| Vomiting | 2 (4) | 2 (4) | 2 (4) | 11 (22) | 6 (12) | 12 (24) |
| Headache | 3 (6) | 1 (2) | 3 (6) | 6 (12) | 7 (14) | 6 (12) |
| Decreased appetite | — | — | 5 (10) | 3 (6) | 4 (8) | 3 (6) |
| Dyspepsia | — | — | 4 (8) | 6 (12) | 3 (6) | 2 (4) |
| Abdominal distension | — | — | 2 (4) | 2 (4) | 3 (6) | 6 (12) |
Data are n (%).
*All patients who received at least one dose of study drug treatment (n = 297) were included in the safety database.